ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 167 filers reported holding ANIKA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554 | -51.4% | 29,725 | -32.2% | 0.00% | -66.7% |
| Q2 2023 | $1,139 | +41.7% | 43,842 | +56.6% | 0.00% | +50.0% |
| Q1 2023 | $804 | -23.4% | 27,989 | -21.1% | 0.00% | -33.3% |
| Q4 2022 | $1,049 | -99.8% | 35,459 | +24.0% | 0.00% | +50.0% |
| Q3 2022 | $681,000 | +25.6% | 28,602 | +17.8% | 0.00% | +100.0% |
| Q2 2022 | $542,000 | +83.7% | 24,288 | +106.7% | 0.00% | 0.0% |
| Q1 2022 | $295,000 | -29.9% | 11,753 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $421,000 | -15.1% | 11,749 | +0.8% | 0.00% | 0.0% |
| Q3 2021 | $496,000 | -2.6% | 11,658 | -0.9% | 0.00% | 0.0% |
| Q2 2021 | $509,000 | +6.0% | 11,765 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $480,000 | -9.9% | 11,772 | -0.1% | 0.00% | 0.0% |
| Q4 2020 | $533,000 | +27.8% | 11,780 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $417,000 | -6.9% | 11,780 | -0.9% | 0.00% | 0.0% |
| Q2 2020 | $448,000 | +29.5% | 11,887 | -0.6% | 0.00% | 0.0% |
| Q1 2020 | $346,000 | -41.3% | 11,959 | +5.3% | 0.00% | -50.0% |
| Q4 2019 | $589,000 | -2.0% | 11,362 | +3.8% | 0.00% | 0.0% |
| Q3 2019 | $601,000 | +32.7% | 10,951 | -1.8% | 0.00% | +100.0% |
| Q2 2019 | $453,000 | +38.1% | 11,149 | +2.8% | 0.00% | 0.0% |
| Q1 2019 | $328,000 | -7.3% | 10,849 | +3.1% | 0.00% | 0.0% |
| Q4 2018 | $354,000 | -18.4% | 10,520 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $434,000 | +34.0% | 10,289 | +1.7% | 0.00% | 0.0% |
| Q2 2018 | $324,000 | -31.1% | 10,115 | +6.9% | 0.00% | -50.0% |
| Q1 2018 | $470,000 | -4.5% | 9,458 | +3.7% | 0.00% | 0.0% |
| Q4 2017 | $492,000 | -5.2% | 9,120 | +2.0% | 0.00% | 0.0% |
| Q3 2017 | $519,000 | +19.6% | 8,940 | +1.6% | 0.00% | 0.0% |
| Q2 2017 | $434,000 | +21.2% | 8,800 | +6.8% | 0.00% | 0.0% |
| Q1 2017 | $358,000 | -7.7% | 8,240 | +4.0% | 0.00% | 0.0% |
| Q4 2016 | $388,000 | +7.8% | 7,920 | +5.2% | 0.00% | 0.0% |
| Q3 2016 | $360,000 | -4.0% | 7,530 | +7.7% | 0.00% | 0.0% |
| Q2 2016 | $375,000 | +28.4% | 6,990 | +7.2% | 0.00% | +100.0% |
| Q1 2016 | $292,000 | +21.2% | 6,520 | +3.2% | 0.00% | 0.0% |
| Q4 2015 | $241,000 | +7.6% | 6,320 | +16.0% | 0.00% | 0.0% |
| Q1 2015 | $224,000 | +4.7% | 5,450 | +3.8% | 0.00% | 0.0% |
| Q4 2014 | $214,000 | – | 5,250 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |